{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:34Z","timestamp":1793367334503,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.josat.2026.210143","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:39:16Z","timestamp":1792391956000},"page":"210143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Substance use disorder treatment research in the National Drug Abuse Treatment Clinical Trials Network: Portfolio analysis of approved studies, 2000\u20132024"],"prefix":"10.1016","author":[{"given":"Sabeeh A.","family":"Baig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landhing M.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah W.","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quandra D.","family":"Blackeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udi E.","family":"Ghitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August F.","family":"Holtyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha A.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.josat.2026.210143_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.2021.13300","article-title":"The Helping to End Addiction Long-term (HEAL) initiative of the National Institutes of Health","volume":"326","author":"Baker","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2026.210143_bb0010","series-title":"An introduction to metascience: The discipline of evaluating the creation and dissemination of research","author":"Bennett","year":"2024"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.joi.2012.10.001","article-title":"The use of percentiles and percentile rank classes in the analysis of bibliometric data: Opportunities and limits","volume":"7","author":"Bornmann","year":"2013","journal-title":"Journal of Informetrics"},{"issue":"2","key":"10.1016\/j.josat.2026.210143_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.55847","article-title":"Investigator- and site-level outcomes of participation in an ED-based clinical trial","volume":"9","author":"Carpenter","year":"2026","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.josat.2026.210143_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00952990.2011.596978","article-title":"Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future","volume":"37","author":"Carroll","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.210143_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0040","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/j.jemermed.2023.06.007","article-title":"Urine toxicology profiles of emergency department patients with untreated opioid use disorder: A multi-site view","volume":"65","author":"Cowan","year":"2023","journal-title":"The Journal of Emergency Medicine"},{"issue":"11","key":"10.1016\/j.josat.2026.210143_bb0050","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2025.27019","article-title":"Emergency department\u2013initiated Buprenorphine for Opioid Use Disorder: A randomized clinical trial","volume":"335","author":"D'Onofrio","year":"2026","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0045","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/ADM.0000000000000595","article-title":"Addiction medicine training fellowships in North America: A recent assessment of progress and needs","volume":"14","author":"Derefinko","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"25","key":"10.1016\/j.josat.2026.210143_bb0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2026.210143_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsat.2015.06.020","article-title":"Implementing effective substance abuse treatments in general medical settings: Mapping the research terrain","volume":"60","author":"Ducharme","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"Elo","year":"2008","journal-title":"Journal of Advanced Nursing"},{"key":"10.1016\/j.josat.2026.210143_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00033","article-title":"NIDA clinical trials network common data elements initiative: Advancing big-data addictive-disorders research","volume":"6","author":"Ghitza","year":"2015","journal-title":"Frontiers in Psychiatry"},{"issue":"1A","key":"10.1016\/j.josat.2026.210143_bb0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1353\/hpu.2014.0067","article-title":"Challenges and opportunities for integrating preventive substance-use-care services in primary care through the affordable care act","volume":"25","author":"Ghitza","year":"2014","journal-title":"Journal of Health Care for the Poor and Underserved"},{"issue":"12","key":"10.1016\/j.josat.2026.210143_bb0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2026.210143_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0740-5472(02)00269-6","article-title":"Putting drug abuse research to use in real-life settings","volume":"23","author":"Hanson","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210143_bb0090","series-title":"Increase in drug overdose deaths involving cocaine: United States, 2009\u20132018","first-page":"384","author":"Hedegaard","year":"2020"},{"key":"10.1016\/j.josat.2026.210143_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100133","article-title":"History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder","volume":"6","author":"Heidbreder","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jrh.12760","article-title":"Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study","volume":"39","author":"Hser","year":"2023","journal-title":"Journal of Rural Health"},{"issue":"9","key":"10.1016\/j.josat.2026.210143_bb0105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qualitative Health Research"},{"issue":"9","key":"10.1016\/j.josat.2026.210143_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002541","article-title":"Relative citation ratio (RCR): A new metric that uses citation rates to measure influence at the article level","volume":"14","author":"Hutchins","year":"2016","journal-title":"PLoS Biology"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14688","article-title":"Methamphetamine use in the United States: Epidemiological update and implications for prevention, treatment, and harm reduction","volume":"1508","author":"Jones","year":"2022","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jsat.2011.09.004","article-title":"Is exposure to an effective contingency management intervention associated with more positive provider beliefs?","volume":"42","author":"Kirby","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210143_bb0125","series-title":"Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment","first-page":"6169","year":"1998"},{"issue":"10118","key":"10.1016\/j.josat.2026.210143_bb0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.josat.2026.210143_bb0135","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-center randomized trial of buprenorphine\u2013naloxone versus clonidine for opioid, detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2026.210143_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1360-0443.2008.02455.x","article-title":"Buprenorphine tapering schedule and illicit opioid use","volume":"104","author":"Ling","year":"2009","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2026.210143_bb0145","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.13375","article-title":"Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: The Cocaine Use Reduction with Buprenorphine (CURB) study","volume":"111","author":"Ling","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210143_bb0150","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jsat.2010.01.009","article-title":"From research to the real world: Buprenorphine in the decade of the Clinical Trials Network","volume":"38","author":"Ling","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53317","article-title":"Trends in treatment need and receipt for substance use disorders in the US","volume":"8","author":"Liu","year":"2025","journal-title":"JAMA Network Open"},{"issue":"10","key":"10.1016\/j.josat.2026.210143_bb0160","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1377\/hlthaff.2024.01289","article-title":"Medicaid expansion boosted specialty treatment episodes for substance use disorder in expansion states, 2010\u201322: Article examines Medicaid expansion and specialty treatment for substance use disorder","volume":"44","author":"Maclean","year":"2025","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.210143_bb0165","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jsat.2009.12.013","article-title":"Partnerships and pathways of dissemination: The National Institute on Drug Abuse\u2014Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network","volume":"38","author":"Martino","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.210143_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/BF03391707","article-title":"Can substance use disorders be managed using the chronic care model? Review and recommendations from a NIDA consensus group","volume":"35","author":"McLellan","year":"2013","journal-title":"Public Health Reviews"},{"key":"10.1016\/j.josat.2026.210143_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2026.108288","article-title":"Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and design","volume":"164","author":"Mooney","year":"2026","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.josat.2026.210143_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.106950","article-title":"Trends and correlates of cocaine use among adults in the United States, 2006\u20132019","volume":"120","author":"Mustaquim","year":"2021","journal-title":"Addictive Behaviors"},{"issue":"2\u20133","key":"10.1016\/j.josat.2026.210143_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2006.08.012","article-title":"Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs","volume":"87","author":"Olmstead","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0190","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11121-022-01337-9","article-title":"NIH primary and secondary prevention research in humans: A portfolio analysis of study designs used in 2012\u20132019","volume":"23","author":"Oyedele","year":"2022","journal-title":"Prevention Science"},{"key":"10.1016\/j.josat.2026.210143_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.63.2.201","article-title":"Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment","volume":"63","author":"Peirce","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"March","key":"10.1016\/j.josat.2026.210143_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18332\/tpc\/184041","article-title":"Portfolio analysis of global tobacco control research funding at the National Cancer Institute, 2000\u20132019","volume":"10","author":"Ricciardone","year":"2024","journal-title":"Tobacco Prevention & Cessation"},{"issue":"5","key":"10.1016\/j.josat.2026.210143_bb0205","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/gim.2017.180","article-title":"The current state of funded NIH grants in implementation science in genomic medicine: A portfolio analysis","volume":"21","author":"Roberts","year":"2019","journal-title":"Genetics in Medicine"},{"issue":"9","key":"10.1016\/j.josat.2026.210143_bb0210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamainternmed.2025.2535","article-title":"Clinical decision support system for primary care of opioid use disorder: A randomized clinical trial","volume":"185","author":"Rossom","year":"2025","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.josat.2026.210143_bb0215","series-title":"Qualitative content analysis in practice","author":"Schreier","year":"2012"},{"issue":"5","key":"10.1016\/j.josat.2026.210143_bb0220","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9744","article-title":"Rapid initiation of injection naltrexone for opioid use disorder: A stepped-wedge cluster randomized clinical trial","volume":"7","author":"Shulman","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210143_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2025.107816","article-title":"Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)","volume":"150","author":"Shulman","year":"2025","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.josat.2026.210143_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107543","article-title":"Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial","volume":"142","author":"Shulman","year":"2024","journal-title":"Contemporary Clinical Trials"},{"issue":"9","key":"10.1016\/j.josat.2026.210143_bb0235","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1360-0443.2007.01913.x","article-title":"Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs","volume":"102","author":"Sindelar","year":"2007","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.josat.2026.210143_bb0240","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/add.13479","article-title":"Adopting the \u2018cascade of care\u2019 framework: An opportunity to close the implementation gap in addiction care?","volume":"111","author":"Soc\u00edas","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210143_bb0245","first-page":"1","article-title":"Drug overdose deaths in the United States, 2001\u20132021","volume":"457","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"issue":"4","key":"10.1016\/j.josat.2026.210143_bb0250","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.psc.2023.03.009","article-title":"National Institute on Drug Abuse: Dissemination of scientific knowledge to improve adolescent health","volume":"46","author":"Subramaniam","year":"2023","journal-title":"Psychiatric Clinics of North America"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13722-021-00238-6","article-title":"The NIDA clinical trials network: Evolving, expanding, and addressing the opioid epidemic","volume":"16","author":"Tai","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210143_bb0260","article-title":"The National Drug Abuse Treatment Clinical Trials Network: Forging a partnership between research knowledge and community practice","volume":"21","author":"Tai","year":"2011","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2026.210143_bb0265","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jsat.2010.01.011","article-title":"The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment","volume":"38","author":"Tai","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2026.210143_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00952990.2011.596976","article-title":"Research partnerships between academic institutions and American Indian and Alaska native tribes and organizations: Effective strategies and lessons learned in a multisite CTN study","volume":"37","author":"Thomas","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.210143_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2025.107954","article-title":"Randomized, placebo-controlled trial of injectable extended-release naltrexone and injectable extended-release buprenorphine for cocaine use disorder (CURB-2): Study rationale and design","volume":"154","author":"Trivedi","year":"2025","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"10.1016\/j.josat.2026.210143_bb0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and naltrexone in methamphetamine use disorder","volume":"384","author":"Trivedi","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.210143_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107724","article-title":"Substance use prevention research funded by the NIH","volume":"206","author":"Villani","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2026.210143_bb0290","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2023.5701","article-title":"Nurse care management for opioid use disorder treatment: The PROUD cluster randomized clinical trial","volume":"183","author":"Wartko","year":"2023","journal-title":"JAMA Internal Medicine"},{"issue":"12","key":"10.1016\/j.josat.2026.210143_bb0295","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.josat.2026.210143_bb0300","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jsat.2009.12.009","article-title":"Study results from the Clinical Trials Network's first 10 years: Where do they lead?","volume":"38","author":"Wells","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.210143_bb0305","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/08897077.2022.2074604","article-title":"Opioid use disorder cascade of care framework design: A roadmap","volume":"43","author":"Williams","year":"2022","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2026.210143_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing communities study","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2026.210143_bb0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamainternmed.2026.0057","article-title":"Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: A randomized clinical trial","volume":"186","author":"Winhusen","year":"2026","journal-title":"JAMA Internal Medicine"},{"issue":"17","key":"10.1016\/j.josat.2026.210143_bb0320","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:47:56Z","timestamp":1793364476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S2949875926002638"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210143","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use disorder treatment research in the National Drug Abuse Treatment Clinical Trials Network: Portfolio analysis of approved studies, 2000\u20132024","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210143"}}